News

The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year

Development project features 150,000 square feet of additional space to accommodate company’s 3PL offerings

Investment features the construction of a high-throughput screening center

BFS technology deal expected to be finalized in Q1

Ruling also shortens time required between the initial two shots and the booster to five months

Deal expands GE’s $3 billion ultrasound business from diagnostics into surgical and therapeutic interventions

Emergency-use clearance of Pfizer drug a major milestone in the fight against the now-omicron-fueled virus in the US

The latest people news happenings over the past month

The new parent company will expand security, monitoring and remedial action for pharma shipments

Firms will merge under the CSafe brand, allowing for delivery of temperature-sensitive items

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Purchase of Engage grows the company’s knowledge in the data and analytics space

Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks

Deal expands pharma giant’s influence in inflammation and immunology markets

Includes 20 million more doses by the end of the 2021

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Via investment partnership with Taishin Holdings, will begin offering manufacturing services in C&GT space

Survey draws attention to the need for improving issues surrounding supply chain visibility

Biden touts provisions administration believes can curb spending on pharmaceuticals

Site is located in the state of Gujarat, a major hub for pharma logistics

Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data

Upon deal completion, group will acquire company’s oncology product portfolio for $846 million

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Latest report indicates that air cargo demand is outperforming pre-Covid stats from 2019

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale